Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Omada Health, Inc. (OMDA : NSDQ)
 
 • Company Description   
Omada Health Inc. provides a range of virtual care programs principally in the United States. The company offers cardiometabolic programs for prediabetes, diabetes and hypertension; a physical therapy program to address musculoskeletal conditions other support programs. Omada Health Inc. is based in San Francisco, California.

Number of Employees: 916

 
 • Price / Volume Information   
Yesterday's Closing Price: $20.53 Daily Weekly Monthly
20 Day Moving Average: 1,252,203 shares
Shares Outstanding: 59.45 (millions)
Market Capitalization: $1,220.49 (millions)
Beta:
52 Week High: $26.89
52 Week Low: $10.28
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 8.62% 7.83%
12 Week 40.81% 36.95%
Year To Date 30.10% 24.14%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
611 Gateway Blvd Suite 120
-
South San Francisco,CA 94080
USA		 ph: 888-987-8337
fax: -		 ir@omadahealth.com http://www.omadahealth.com
 
 • General Corporate Information   
Officers
Sean Duffy - Chief Executive Officer and Director
Steve Cook - Chief Financial Officer
Jeryl Hilleman - Director
Anne Beal - Director
Trevor Fetter - Director

Peer Information
Omada Health, Inc. (CHCR)
Omada Health, Inc. (ESRX)
Omada Health, Inc. (MYDP)
Omada Health, Inc. (COR)
Omada Health, Inc. (GBCS)
Omada Health, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 68170A108
SIC: 8000
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/06/26
Share - Related Items
Shares Outstanding: 59.45
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $1,220.49 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.00 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.01 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/06/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 5.21
Price/Cash Flow: -
Price / Sales: 4.31
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -162.50%
Sales Growth
vs. Year Ago Period: 42.00%
vs. Previous Quarter: 2.90%
ROE
06/30/26 - -
03/31/26 - -1.82
12/31/25 - -6.44
ROA
06/30/26 - -
03/31/26 - -1.36
12/31/25 - -4.75
Current Ratio
06/30/26 - -
03/31/26 - 3.92
12/31/25 - 3.60
Quick Ratio
06/30/26 - -
03/31/26 - 3.87
12/31/25 - 3.54
Operating Margin
06/30/26 - -
03/31/26 - -1.44
12/31/25 - -4.09
Net Margin
06/30/26 - -
03/31/26 - -2.22
12/31/25 - -4.91
Pre-Tax Margin
06/30/26 - -
03/31/26 - -2.22
12/31/25 - -4.91
Book Value
06/30/26 - -
03/31/26 - 3.94
12/31/25 - 3.97
Inventory Turnover
06/30/26 - -
03/31/26 - 25.60
12/31/25 - 32.16
Debt-to-Equity
06/30/26 - -
03/31/26 - 0.00
12/31/25 - 0.00
Debt-to-Capital
06/30/26 - -
03/31/26 - 0.00
12/31/25 - 0.00
 

Powered by Zacks Investment Research ©